Clinical characteristics of Gaucher's disease in Spain. Preliminary results of a national inquiry;Características clínicas de la enfermedad de Gaucher tipo I en España. Resultados preliminares de una encuesta nacional

Medicina Clinica

Volumn 109, Issue 16, 1997, Pages 619-622

  Giraldo, Pilar ^a   Pérez Calvo, Juan Ignacio ^b   Giralt, Manuel ^b   Pocovi, Miguel ^b   Aguiar, M ^b   Amerigo M J ^b   Aporta, R ^b   Calabuig, J R ^b   Castellano, G ^b   Espinos D ^b   Fernandez Epifanio J L ^b   Ferriols, E ^b   De Garcia Jalon A ^b   Garijo, E ^b   Gimenez Garrido F ^b   Gracia Antequera, M ^b   Heiniger, D ^b   Larrabeiti, L ^b   Lopez Munoz J ^b   Loyola, L ^b   Luno E ^b   Martin Nunez G ^b   Martin Vivaldi R ^b   Martinez Odriozola P ^b   Morillas, M ^b   Mut Barbera E ^b   Roca, M ^b   Rodriguez Lopez I ^b   Romero Gallardo, R ^b   Romero Gomez M ^b   Sanjurjo, P ^b   Santos, A ^b   Sarria, A ^b   De La Serna, F J ^b   Torralba, M A ^b   Zarate F J ^b   more..

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLASSIFICATION; FEMALE; GAUCHER DISEASE; GENETICS; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MALE; SPAIN;

ADULT; DATA COLLECTION; FEMALE; GAUCHER DISEASE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 0031560130     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gaucher PCE. De l'epitheliome primitif de la rate, hypertrophie idiopathique de la rate sans léucémie. [tesis doctoral]. Paris, 1882.
2. Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides. II, Evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun 1965; 18: 221-225.
3. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 1989; 4: 87-96.
4. Grabowski GA. Gaucher disease. Enzymology, genetics, and treatment. Adv Hum Gen 1993; 21: 377-441.
5. Aerts JM, Goudsmit R, Tager JM. Proceedings of the I Workshop of the European Working Group on Gaucher Disease. Trieste 13-16 octubre 1994. Drukkenj Universiteit van Amsterdam. Amsterdam, 1995.
6. National Institutes of Health Technology Assessment Conference on. Gaucher Disease: Current Issues in Diagnosis and Treatment. Bethesda. 27 febrero-1 marzo 1995.
7. Miescher PA, Jaffé ER, Beris P. Gaucher disease, hematologic, skeletal, visceral and biochemical effects. Current understanding, recent advances and future directions. Semin Hematol 1995; 32 (Supl 1): 1-52
8. Horowitz M, Zimran A. Mutations causing Gaucher disease Hum Mut 1994; 3: 1-11.
9. Barton NW, Furbish PS, Murray GJ, Garfield M, Brady RO. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci USA 1990; 87: 1.913-1.916.
10. Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC et al. Replacement therapy for inherited enzyme deficiency. Macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 1991; 324: 1.464-1.470
11. Giralt M, Rubio-Félix D. Enfermedad de Gaucher ¿Olvidar el pasado? Sangre 1994; 39: 1-2.
12. Pérez Calvo JI, Pastores GM. Tratamiento de la enfermedad de Gaucher tipo I. ¿Hacia la solución definitiva? Med Clin (Barc) 1994; 103: 16-18.
13. Garcia-Antequera M, Jorro F, Cambra J, Sancho-Tello R, Salabert J, Iborra J et al. Enfermedad de Gaucher juvenil. Aportacion de un nuevo caso. Arch Pediat 1981; 32: 349-356.
14. Jiménez M, Romero R, Carrasco F, Herrerias JM. Enfermedad de Gaucher tipo I con factor anticoagulante y embarazo. An Med Intern (Madrid) 1991; 8: 294-295.
15. Modrego PJ, Garzarán G, González N, Baiges JJ, Gazulla J. Complicaciones de la Enfermedad de Gaucher. Rev Clin Esp 1992; 191: 311-313.
16. Giraldo P, Pérez-Calvo J, Rubio-Félix D, Cortés T, Mayayo P, Giralt M. Gaucher disease type I. Clinical features of 10 patients and therapeutic results with alglucerase in symptomatic cases. En: Aerts JM, Goudsmit R, Tager JM editors.. Proceedings of the I Workshop of the European Working Group of Gaucher Disease. Amsterdam. 1995; 91-92.
17. Giraldo P, Pérez-Calvo J, Cortés J, Civeira F, Rubio-Félix D. Enfermedad de Gaucher tipo I: caracteristicas clínicas, evolutivas y terapéuticas en 8 casos. Sangre 1994; 39: 3-7.
18. Cormand B, Vilageliu LL, Bruguera JM, Balcells S, González-Duarte R, Grinberg D et al. Gaucher disease in Spanish patients: analysis of eight mutations. Hum Mut 1995; 5: 303-309.
19. Zimran A, Gross E, West C, Sorge J, Kubitz M, Beutler E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet 1989; 349-352.
20. Raghavan SS, Topol J, Kolodny EH. Leukocyte B-glucosidase in homozigotes and heterozygotes for Gaucher disease. Am J Hum Genet 1980; 32: 158-173.
21. Theophilus B, Latham T, Grabowski GA, Smith FI. Gaucher disease: molecular heterogeneity and phenotype-genotype correlations. Am J Hum Genet 1989; 45: 212-216.
22. Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA. Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet 1993; 52: 1.094-1.101.
23. Sidransky E, Bottler A, Stubblefield B, Ginns EI. DNA mutational analysis of type I and type 3. Gaucher patients: How cell do mutations predict phenotype? Hum Mut 1994; 3: 25-28.
24. Strasberg PM, Triggs-Raine BL, Warren IB, Skomorowski MA, Mclnnes B, Becker LE et al. Genotype-phenotype pitfalls n Gaucher disease. J Clin Lab Anal 1994; 8: 228-236.
25. Paradela A, Arias I, González M, Martínez J, Regueira A. Alglucerasa en la enfermedad de Gaucher: ¿es la alternative más eficaz la más eficiente? Comunicaciones al XL Congreso de la Sociedad Espan̄ola de Farmacia Hospitalaria. Toledo, 1995; 41-42.
26. Pérez Calvo JI, Giraldo P. Alglucerasa en la enfermedad de Gaucher: la alternativa más eficiente puede no ser la más eficaz, la fábula de «El traje nuevo del Rey». Farm Hosp 1996; 20: 201-202.
27. Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A et al. Gaucher disease, clinical laboratory, radiologic and genetic features of 53 patients. Medicine (Baltimore) 1992; 71: 337-354.
28. Grabowsky GA. Genotype-phenotype correlations in Gaucher disease. En: NIH Technology Assessment Conference Statement. Gaucher Disease: current issues in diagnosis and treatment. Bethesda: National Institutes of Health, 1995; 43-46.
29. Rademakers R. Radiological evaluation of Gaucher bone disease Semin Hematol 1995; 32 (Supl 1): 14-19.
30. Roca M, Mota J, Giraldo P, Pérez Calvo JI, Gómez-Pereda R, Giralt M La resonancia magnética en el diagnóstico de extension y las complicaciones óseas de la enfermedad de Gaucher tipo 1. Rev Clin Esp 1997. En prensa.